Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Lilly joins Personal Connected Health Alliance

Samsung, AT&T and IPSOS Healthcare also sign up

Digital pharmaLilly has joined the Personal Connected Health Alliance, a US non-profit organisation that aims to make health and wellness an effortless part of daily life.

Alongside the pharma firm the PCH Alliance has also welcomed the likes of Samsung AT&T and IPSOS Healthcare.

As part of their membership each of the organisations can nominate an executive to the PCH Alliance board of managers - for Lilly this will be its director of software device solutions James Parshall.

Patricia Mechael, executive vice president at the Personal Connected Health Alliance, said: "We have a very strong leadership team in place and are pleased to welcome the newest members to the board of managers, representing major players in the connected health ecosystem.

"Each of the individuals on the PCHAlliance Board share deep experience, passionate commitment and an innovative approach to helping shape the course of human health and healthcare through the use of personal health tools."

Also joining the PCHAlliance are France’s Voluntis, a therapeutic companion software firm working with Sanofi in diabetes, and the Danish Health Data Authority.

Horst Merkle, chair, PCHAlliance board of managers, and director of digital Solutions at Roche Diabetes Care, commented: "We are truly becoming a platform that is representative of a highly diverse and growing personal connected health ecosystem.

1st June 2017

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics